Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4054)
All Articles published online
|
Jan 7, 2008 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liang HL, Ouyang Q. A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis. World J Gastroenterol 2008; 14(1): 114-119 [PMID: 18176972 DOI: 10.3748/wjg.14.114] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i1/114.htm |
| Number | Citing Articles |
| 1 |
Pierre Desreumaux, Laurent Dubuquoy. PPARγ agonists as a new class of effective treatment for ulcerative colitis. Inflammatory Bowel Diseases 2009; 15(6): 959 doi: 10.1002/ibd.20765
|
| 2 |
Joana Torres, Silvio Danese, Jean-Frédéric Colombel. New therapeutic avenues in ulcerative colitis: thinking out of the box. Gut 2013; 62(11): 1642 doi: 10.1136/gutjnl-2012-303959
|
| 3 |
Harry Martin. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2010; 690(1-2): 57 doi: 10.1016/j.mrfmmm.2009.09.009
|
| 4 |
S. C. NG, M. A. KAMM. Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis. Alimentary Pharmacology & Therapeutics 2008; 28(7): 815 doi: 10.1111/j.1365-2036.2008.03800.x
|
| 5 |
Md. Sahab Uddin, Md. Tanvir Kabir, Md. Jakaria, Abdullah Al Mamun, Kamal Niaz, Md. Shah Amran, George E. Barreto, Ghulam Md Ashraf. Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK. Neurotoxicity Research 2019; 36(3): 583 doi: 10.1007/s12640-019-00047-5
|
| 6 |
Andrew N Milestone, Marietta Iacucci, Subrata Ghosh. Is rosiglitazone a promising treatment for ulcerative colitis?. Nature Clinical Practice Gastroenterology & Hepatology 2008; 5(9): 486 doi: 10.1038/ncpgasthep1226
|
| 7 |
Seyede Sara Seyedizade, Khashayar Afshari, Saba Bayat, Fatemeh Rahmani, Saeideh Momtaz, Nima Rezaei, Amir Hossein Abdolghaffari. Current Status of M1 and M2 Macrophages Pathway as Drug Targets for Inflammatory Bowel Disease. Archivum Immunologiae et Therapiae Experimentalis 2020; 68(2) doi: 10.1007/s00005-020-00576-4
|
| 8 |
Harry Martin. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2009; 669(1-2): 1 doi: 10.1016/j.mrfmmm.2009.06.009
|
| 9 |
Amy Kang, Seong-woo Lim. Therapeutic Effects of Gaejigayonggolmoryo-tang on Dextran Sodium Sulfate-induced Ulcerative Colitis in Mice. The Journal of Internal Korean Medicine 2017; 38(6): 1021 doi: 10.22246/jikm.2017.38.6.1021
|
| 10 |
Gustavo Henrique Oliveira da Rocha, Marina de Paula-Silva, Milena Fronza Broering, Pablo Rhasan dos Santos Scharf, Larissa Satiko Alcântara Sekimoto Matsuyama, Silvya Stuchi Maria-Engler, Sandra Helena Poliselli Farsky. Pioglitazone-Mediated Attenuation of Experimental Colitis Relies on Cleaving of Annexin A1 Released by Macrophages. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.591561
|
| 11 |
Kalina Duszka, Alexandre Picard, Sandrine Ellero-Simatos, Jiapeng Chen, Marianne Defernez, Eeswari Paramalingam, Anna Pigram, Liviu Vanoaica, Cécile Canlet, Paolo Parini, Arjan Narbad, Hervé Guillou, Bernard Thorens, Walter Wahli. Intestinal PPARγ signalling is required for sympathetic nervous system activation in response to caloric restriction. Scientific Reports 2016; 6(1) doi: 10.1038/srep36937
|
| 12 |
Catherine Le Berre, Giulia Roda, Marijana Nedeljkovic Protic, Silvio Danese, Laurent Peyrin-Biroulet. Modern use of 5-aminosalicylic acid compounds for ulcerative colitis. Expert Opinion on Biological Therapy 2020; 20(4): 363 doi: 10.1080/14712598.2019.1666101
|
| 13 |
Kalina Duszka, András Gregor, Hervé Guillou, Jürgen König, Walter Wahli. Peroxisome Proliferator-Activated Receptors and Caloric Restriction—Common Pathways Affecting Metabolism, Health, and Longevity. Cells 2020; 9(7): 1708 doi: 10.3390/cells9071708
|
| 14 |
Shaoshuai Tang, Wei Zhong, Tingting Li, Yuanyue Li, Gang Song. Isochlorogenic acid A alleviates dextran sulfate sodium-induced ulcerative colitis in mice through STAT3/NF-кB pathway. International Immunopharmacology 2023; 118: 109989 doi: 10.1016/j.intimp.2023.109989
|
| 15 |
Sa-Haeng Kang, Yong-Deok Jeon, Kwang-Hyun Moon, Jeong-Ho Lee, Dae-Geun Kim, Wook Kim, Hyun Myung, Jong-Sung Kim, Hyun-Ju Kim, Keuk-Soo Bang, Jong-Sik Jin. AroniaBerry Extract Ameliorates the Severity of Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice. Journal of Medicinal Food 2017; 20(7): 667 doi: 10.1089/jmf.2016.3822
|
| 16 |
Konstansa Lazarević, Aleksandar Nagorni, Miroslav Jeremić. Carbohydrate Intake, Glycemic Index, Glycemic Load and Risk of Gastric Cancer. Central European Journal of Public Health 2009; 17(2): 75 doi: 10.21101/cejph.a3501
|
| 17 |
Michael Rohr, Chandrakala Aluganti Narasimhulu, Dhara Sharma, Mitsushita Doomra, Aladdin Riad, Saleh Naser, Sampath Parthasarathy. Inflammatory Diseases of the Gut. Journal of Medicinal Food 2018; 21(2): 113 doi: 10.1089/jmf.2017.0138
|
| 18 |
Ming-Hsi Wang, Jessica J Friton, Laura E Raffals, Jonathan A Leighton, Shabana F Pasha, Michael F Picco, Kelly C Cushing, Kelly Monroe, Billy D Nix, Rodney D Newberry, William A Faubion. Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2019; 13(8): 1036 doi: 10.1093/ecco-jcc/jjz017
|
| 19 |
Mahmoud H. Mosli, Brian G. Feagan, William J. Sandborn, Geert DʼHaens, Cynthia Behling, Keith Kaplan, David K. Driman, Lisa M. Shackelton, Kenneth A. Baker, John K. MacDonald, Margaret K. Vandervoort, Karel Geboes, Barrett G. Levesque. Histologic Evaluation of Ulcerative Colitis. Inflammatory Bowel Diseases 2014; 20(3): 564 doi: 10.1097/01.MIB.0000437986.00190.71
|
| 20 |
Stéphanie Da Silva, Åsa V Keita, Sofie Mohlin, Sven Påhlman, Vassilia Theodorou, Ingrid Påhlman, Jan P Mattson, Johan D Söderholm. A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models. Inflammatory Bowel Diseases 2018; 24(4): 792 doi: 10.1093/ibd/izx079
|
| 21 |
Yunjie Cai, Yina Huang, Liang Qiu, Xuan Mi, Yu Wang, Xueying Tao, Hua Wei. Theabrownins prevents DSS-induced colitis via modulating PPAR-γ and NF-κB signaling pathways in mice. Journal of Functional Foods 2023; 109: 105812 doi: 10.1016/j.jff.2023.105812
|
| 22 |
Jennifer L. Lund, Til Stürmer, Carol Q. Porter, Robert S. Sandler, Michael D. Kappelman. Thiazolidinedione use and ulcerative colitis-related flares: An exploratory analysis of administrative data. Inflammatory Bowel Diseases 2011; 17(3): 787 doi: 10.1002/ibd.21348
|
| 23 |
Yeon-Yong Kim, Gayeong Hur, Hyun-Jae Jang, Seungwon Jeong, Seung Woong Lee, Seung-Jae Lee, Mun-Chual Rho, Sang-Hyun Kim, Soyoung Lee. Ferulic Acid Derivatives Ameliorate Intestine Barrier Destruction by Alleviating Inflammatory Responses in Dextran Sulfate Sodium-Induced Inflammatory Bowel Disease. Toxics 2024; 12(4): 268 doi: 10.3390/toxics12040268
|
| 24 |
Alexandra M. Vlk, Daniel Prantner, Kari Ann Shirey, Darren J. Perkins, Marguerite S. Buzza, Vivek Thumbigere-Math, Achsah D. Keegan, Stefanie N. Vogel, Alejandro Aballay. M2a macrophages facilitate resolution of chemically-induced colitis in TLR4-SNP mice. mBio 2023; 14(5) doi: 10.1128/mbio.01208-23
|
| 25 |
Luca Pastorelli, Theresa T Pizarro, Fabio Cominelli, Maurizio Vecchi. Emerging drugs for the treatment of ulcerative colitis. Expert Opinion on Emerging Drugs 2009; 14(3): 505 doi: 10.1517/14728210903146882
|
| 26 |
Gajanan D. Katkar, Ibrahim M. Sayed, Mahitha Shree Anandachar, Vanessa Castillo, Eleadah Vidales, Daniel Toobian, Fatima Usmani, Joseph R. Sawires, Geoffray Leriche, Jerry Yang, William J. Sandborn, Soumita Das, Debashis Sahoo, Pradipta Ghosh. Artificial intelligence-rationalized balanced PPARα/γ dual agonism resets dysregulated macrophage processes in inflammatory bowel disease. Communications Biology 2022; 5(1) doi: 10.1038/s42003-022-03168-4
|
| 27 |
Mahmoud H Mosli, Claire E Parker, Sigrid A Nelson, Kenneth A Baker, John K MacDonald, GY Zou, Brian G Feagan, Reena Khanna, Barrett G Levesque, Vipul Jairath. Histologic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database of Systematic Reviews 2017; 2017(7) doi: 10.1002/14651858.CD011256.pub2
|
| 28 |
Umid Kumar Shrestha, Ouafae Karimi, Bart J. A. Crusius, Feng Zhou, Zhongli Wang, Zhitao Chen, A. A. van Bodegraven, Jun Xiao, Servaas A. Morré, Hongling Wang, Jin Li, Bing Xia. Distribution of peroxisome proliferator–activated receptor–gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2010; 16(2): 312 doi: 10.1002/ibd.21059
|
| 29 |
Shomron Ben-Horin, Yehuda Chowers. Advances in the Management of Inflammatory Bowel Disease. 2013; : 124 doi: 10.2217/ebo.12.227
|
| 30 |
Gitte Pedersen, Jørn Brynskov. Topical Rosiglitazone Treatment Improves Ulcerative Colitis by Restoring Peroxisome Proliferator-Activated Receptor-γ Activity. American Journal of Gastroenterology 2010; 105(7): 1595 doi: 10.1038/ajg.2009.749
|
| 31 |
L. De Benedictis, M. A. Potenza, S. Gagliardi, A. Zigrino, M. Montagnani, M. A. De Salvia. Rosiglitazone reverses increased duodenal inhibitory response in spontaneously hypertensive rats. Neurogastroenterology & Motility 2012; 24(1) doi: 10.1111/j.1365-2982.2011.01798.x
|
| 32 |
Robert Battat, Marjolijn Duijvestein, Leonardo Guizzetti, Daksh Choudhary, Brigid S. Boland, Parambir S. Dulai, Claire E. Parker, Tran M. Nguyen, Siddharth Singh, Niels Vande Casteele, Rish K. Pai, Brian G. Feagan, William J. Sandborn, Vipul Jairath. Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Journal of Gastroenterology 2019; 114(5): 733 doi: 10.14309/ajg.0000000000000111
|
| 33 |
Xiangli Qing, Lin Wang, Shuangshuang Fang, Yanran Ban, Zhuotai Zhong, Weiqi Sun, Chenhui Zhang, Tao Zhang, Yang Yang, Wei Wei. Association of Antidiabetic Drug Target Genes with Inflammatory Bowel Disease: A Mendelian Randomization Study. Journal of Inflammation Research 2024; : 1389 doi: 10.2147/JIR.S441231
|
| 34 |
Elizabeth Managlia, Rebecca B. Katzman, Jeffrey B. Brown, Terrence A. Barrett. Antioxidant Properties of Mesalamine in Colitis Inhibit Phosphoinositide 3-Kinase Signaling in Progenitor Cells. Inflammatory Bowel Diseases 2013; 19(10): 2051 doi: 10.1097/MIB.0b013e318297d741
|
| 35 |
Kalina Duszka, Walter Wahli. Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors. International Journal of Molecular Sciences 2018; 19(8): 2210 doi: 10.3390/ijms19082210
|
| 36 |
Stephanie A. Cevallos, Jee-Yon Lee, Eric M. Velazquez, Nora J. Foegeding, Catherine D. Shelton, Connor R. Tiffany, Beau H. Parry, Annica R. Stull-Lane, Erin E. Olsan, Hannah P. Savage, Henry Nguyen, Star S. Ghanaat, Austin J. Byndloss, Ilechukwu O. Agu, Renée M. Tsolis, Mariana X. Byndloss, Andreas J. Bäumler, Sabine Ehrt. 5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-γ Signaling in the Intestinal Epithelium. mBio 2021; 12(1) doi: 10.1128/mBio.03227-20
|
| 37 |
Brian G Feagan, John K MacDonald, Brian G Feagan. Cochrane Database of Systematic Reviews. 2012; doi: 10.1002/14651858.CD000543.pub3
|
| 38 |
Erjin Wang, Run Han, Mingyue Wu, Yuan He, Yaxin Cheng, Jiahong Lu, Ying Zheng. Size-dependent macrophage-targeting of mannose-modified rosiglitazone liposomes to alleviate inflammatory bowel disease. Chinese Chemical Letters 2024; 35(1): 108361 doi: 10.1016/j.cclet.2023.108361
|
| 39 |
Mate Kiss, Zsolt Czimmerer, Laszlo Nagy. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology. Journal of Allergy and Clinical Immunology 2013; 132(2): 264 doi: 10.1016/j.jaci.2013.05.044
|
| 40 |
Gustavo Henrique Oliveira da Rocha, Rodrigo Azevedo Loiola, Marina de Paula-Silva, Fumitaka Shimizu, Takashi Kanda, Andrea Vieira, Fabien Gosselet, Sandra Helena Poliselli Farsky. Pioglitazone Attenuates the Effects of Peripheral Inflammation in a Human In Vitro Blood–Brain Barrier Model. International Journal of Molecular Sciences 2022; 23(21): 12781 doi: 10.3390/ijms232112781
|